Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Schäfer-Korting

Showing results (51-60 of 212) with videos related to

Pageof 22
Sort By:
European Journal of Clinical Pharmacology|January 1, 1984
Pharmacokinetics of nadolol in healthy subjectsM Schäfer-Korting, N Bach, H Knauf, et al.
The Clinical Investigator|December 1, 1994
Liposomal tretinoin for uncomplicated acne vulgarisM Schäfer-Korting, H C Korting, E Ponce-Pöschl
Drug Safety|June 1, 1996
Topical glucocorticoids with improved risk-benefit ratio. Rationale of a new conceptM Schäfer-Korting, M H Schmid, H C Korting
Mykosen|July 1, 1986
[Antimicrobial effects of in vitro-simulated ketoconazole-cantharidin blister fluid levels on candida albicans]H C Korting, U Schlaf-Maier, M Schäfer-Korting
Infection|September 1, 1995
Influence of serum protein binding on the in vitro activity of anti-fungal agentsM Schäfer-Korting, H C Korting, W Rittler, et al.
Skin Pharmacology and Physiology|April 17, 2004
Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoagingA Roeder, M Schaller, M Schäfer-Korting, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1984
Plasma, cantharides blister fluid, and suction blister fluid levels of ceftizoxime after single intramuscular application for gonorrheaH C Korting, M Schäfer-Korting, R Haag, et al.
Pharmaceutical Research|June 1, 1997
Prednicarbate biotransformation in human foreskin keratinocytes and fibroblastsA Gysler, K Lange, H C Korting, et al.
Arzneimittel-Forschung|January 1, 1989
Bactericidal effect of cefodizime against beta-lactamase-producing Neisseria gonorrhoeae in vitro. A comparison of level profiles in serum and tissue after intramuscular and intravenous administration in manH C Korting, A Lukacs, M Schäfer-Korting, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 9, 2000
Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skinV Jenning, A Gysler, M Schäfer-Korting, et al.
Pageof 22

Showing results (51-60 of 212) with videos related to

Sort By:
Pageof 22
European Journal of Clinical Pharmacology|January 1, 1984
Pharmacokinetics of nadolol in healthy subjectsM Schäfer-Korting, N Bach, H Knauf, et al.
The Clinical Investigator|December 1, 1994
Liposomal tretinoin for uncomplicated acne vulgarisM Schäfer-Korting, H C Korting, E Ponce-Pöschl
Drug Safety|June 1, 1996
Topical glucocorticoids with improved risk-benefit ratio. Rationale of a new conceptM Schäfer-Korting, M H Schmid, H C Korting
Mykosen|July 1, 1986
[Antimicrobial effects of in vitro-simulated ketoconazole-cantharidin blister fluid levels on candida albicans]H C Korting, U Schlaf-Maier, M Schäfer-Korting
Infection|September 1, 1995
Influence of serum protein binding on the in vitro activity of anti-fungal agentsM Schäfer-Korting, H C Korting, W Rittler, et al.
Skin Pharmacology and Physiology|April 17, 2004
Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoagingA Roeder, M Schaller, M Schäfer-Korting, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1984
Plasma, cantharides blister fluid, and suction blister fluid levels of ceftizoxime after single intramuscular application for gonorrheaH C Korting, M Schäfer-Korting, R Haag, et al.
Pharmaceutical Research|June 1, 1997
Prednicarbate biotransformation in human foreskin keratinocytes and fibroblastsA Gysler, K Lange, H C Korting, et al.
Arzneimittel-Forschung|January 1, 1989
Bactericidal effect of cefodizime against beta-lactamase-producing Neisseria gonorrhoeae in vitro. A comparison of level profiles in serum and tissue after intramuscular and intravenous administration in manH C Korting, A Lukacs, M Schäfer-Korting, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|May 9, 2000
Vitamin A loaded solid lipid nanoparticles for topical use: occlusive properties and drug targeting to the upper skinV Jenning, A Gysler, M Schäfer-Korting, et al.
Pageof 22